Sirpa Tenhola

Kotka, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Puberty-Promoting Treatment and Psychosocial Well-Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial.

Puberty-Promoting Treatment and Psychosocial Well-Being in Boys With Constitutional Delay of Puberty: A Randomized Controlled Trial.

Journal: Clinical endocrinology

Published: April 14, 2025

Impact of aromatase inhibition on bone mineral density and structure: a randomized controlled trial in boys with delayed puberty.

Impact of aromatase inhibition on bone mineral density and structure: a randomized controlled trial in boys with delayed puberty.

Journal: European journal of endocrinology

Published: February 18, 2025

Health-related quality of life in boys with constitutional delay of growth and puberty.

Health-related quality of life in boys with constitutional delay of growth and puberty.

Journal: Frontiers in endocrinology

Published: August 26, 2022

Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty.

Circulating Liver-enriched Antimicrobial Peptide-2 Decreases During Male Puberty.

Journal: Journal of the Endocrine Society

Published: December 04, 2021

Serum testosterone and oestradiol predict the growth response during puberty promoting treatment.

Serum testosterone and oestradiol predict the growth response during puberty promoting treatment.

Journal: Clinical endocrinology

Published: June 17, 2021

Bone structure assessed with pQCT in prepubertal males with delayed puberty or congenital hypogonadotropic hypogonadism.

Bone structure assessed with pQCT in prepubertal males with delayed puberty or congenital hypogonadotropic hypogonadism.

Journal: Clinical endocrinology

Published: February 12, 2021

Association of Serum Total Osteocalcin Concentrations With Endogenous Glucocorticoids and Insulin Sensitivity Markers in 12-Year-Old Children: A Cross-Sectional Study.

Association of Serum Total Osteocalcin Concentrations With Endogenous Glucocorticoids and Insulin Sensitivity Markers in 12-Year-Old Children: A Cross-Sectional Study.

Journal: Frontiers in endocrinology

Published: July 13, 2019

Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.

Anti-Müllerian hormone and letrozole levels in boys with constitutional delay of growth and puberty treated with letrozole or testosterone.

Journal: Human reproduction (Oxford, England)

Published: July 09, 2019

Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children.

Fibroblast Growth Factor 21, Adiponectin, and Irisin as Markers of Unfavorable Metabolic Features in 12-Year-Old Children.

Journal: Journal of the Endocrine Society

Published: December 07, 2018

Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.

Letrozole versus testosterone for promotion of endogenous puberty in boys with constitutional delay of growth and puberty: a randomised controlled phase 3 trial.

Journal: The Lancet. Child & adolescent health

Published: September 28, 2018

Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children.

Serum IL-1 Receptor Antagonist Concentrations Associate With Unfavorable Metabolic Features in 12-Year-Old Children.

Journal: Journal of the Endocrine Society

Published: May 23, 2018

Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.

Impaired growth and intracranial calcifications in autosomal dominant hypocalcemia caused by a GNA11 mutation.

Journal: European journal of endocrinology

Published: February 06, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026